Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
They are not intended to diagnose or treat medical conditions
For Further Information Regarding this Report: Request a Free Sample Type 2 diabetes and obesity are major health issues that affect a large number of people worldwide
In a Phase 2 randomised controlled trial published in the New England Journal of Medicine in 2023 (Jastreboff et al., NEJM 2023), adults with obesity (without type 2 diabetes) who received the highest dose of retatrutide (12 mg weekly) achieved a mean body weight reduction of approximately 24% over 48 weeks
Supporting your wellness is your personal business
Each time you look in the mirror you grab the pooch and wish it werent there
Retail media and loyalty ecosystems are helping consumers discover products that align with their health goals, including GLP-1friendly formats
US$ 22.96
US$ 24.30
US$ 21.14
US$ 20.62
US$ 28.65
US$ 24.84
US$ 20.08
